(HWKN) Hawkins - Ratings and Ratios

Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US4202611095

Chemicals, Water, Ingredients, Nutrition, Blends

HWKN EPS (Earnings per Share)

EPS (Earnings per Share) of HWKN over the last years for every Quarter: "2020-03": 0.22414117647059, "2020-06": 0.5538094365595, "2020-09": 0.57376046089109, "2020-12": 0.37322188349597, "2021-03": 0.4284602137347, "2021-06": 0.78514328345523, "2021-09": 0.66853988391729, "2021-12": 0.48464468572189, "2022-03": 0.50178378275803, "2022-06": 0.93636342025816, "2022-09": 0.85890565875678, "2022-12": 0.51172148772545, "2023-03": 0.55235295796353, "2023-06": 1.1150346455494, "2023-09": 1.1041357531484, "2023-12": 0.71195228460873, "2024-03": 0.66089798414648, "2024-06": 1.3808387642786, "2024-09": 1.156184084372, "2024-12": 0.71956886227545, "2025-03": 0.78314466615503, "2025-06": 1.4019297857822,

HWKN Revenue

Revenue of HWKN over the last years for every Quarter: 2020-03: 132.413, 2020-06: 143.172, 2020-09: 147.801, 2020-12: 142.927, 2021-03: 162.971, 2021-06: 181.241, 2021-09: 183.277, 2021-12: 187.05, 2022-03: 222.973, 2022-06: 246.543, 2022-09: 241.192, 2022-12: 219.218, 2023-03: 228.145, 2023-06: 251.12, 2023-09: 236.526, 2023-12: 208.496, 2024-03: 223.02, 2024-06: 255.879, 2024-09: 247.029, 2024-12: 226.205, 2025-03: 245.318, 2025-06: 293.272,

Description: HWKN Hawkins

Hawkins Inc (NASDAQ:HWKN) is a US-based company operating in the water treatment and specialty ingredients sector, with a diversified business model across three segments: Water Treatment, Industrial, and Health and Nutrition. The companys Water Treatment segment provides a range of chemicals, products, and services for various water treatment applications, while the Industrial segment serves multiple industries, including agriculture, chemical processing, and pharmaceuticals, with a range of industrial chemicals and custom blending services. The Health and Nutrition segment caters to the nutraceutical, functional food and beverage, and personal care industries, offering ingredient distribution, processing, and formulation solutions.

From a financial perspective, Hawkins Inc has a market capitalization of approximately $3.36 billion, with a price-to-earnings ratio of 40.01 and a forward P/E of 36.23, indicating a relatively high valuation. The companys return on equity (RoE) stands at 18.93%, suggesting a decent level of profitability. To further evaluate the companys performance, key performance indicators (KPIs) such as revenue growth, gross margin, and operating cash flow margin can be examined. For instance, a review of the companys historical financials reveals a steady increase in revenue over the past few years, with a compound annual growth rate (CAGR) of around 10%. Additionally, Hawkins Incs gross margin has remained relatively stable, indicating a consistent level of pricing power and cost management.

To gain a deeper understanding of Hawkins Incs operational efficiency, metrics such as inventory turnover, accounts receivable turnover, and capital expenditure (capex) as a percentage of revenue can be analyzed. For example, a high inventory turnover ratio would suggest that the company is effectively managing its inventory levels, minimizing waste and excess stock. Furthermore, a review of the companys cash flow statement reveals a healthy level of operating cash flow, which can be used to fund future growth initiatives or return value to shareholders through dividends or share buybacks.

From a technical analysis perspective, Hawkins Incs stock price is currently trading above its 20-day and 50-day simple moving averages (SMA), indicating a positive short-term trend. The stocks relative strength index (RSI) can be calculated to assess its momentum and potential for future price movements. For instance, if the RSI is above 70, it may indicate that the stock is overbought and due for a correction, while an RSI below 30 could suggest that the stock is oversold and presents a buying opportunity.

HWKN Stock Overview

Market Cap in USD 3,561m
Sub-Industry Commodity Chemicals
IPO / Inception 1993-10-27

HWKN Stock Ratings

Growth Rating 84.6%
Fundamental 77.4%
Dividend Rating 60.6%
Return 12m vs S&P 500 25.2%
Analyst Rating 4.0 of 5

HWKN Dividends

Dividend Yield 12m 0.49%
Yield on Cost 5y 3.12%
Annual Growth 5y 7.90%
Payout Consistency 97.9%
Payout Ratio 17.7%

HWKN Growth Ratios

Growth Correlation 3m 86.7%
Growth Correlation 12m 52.5%
Growth Correlation 5y 97%
CAGR 5y 66.75%
CAGR/Max DD 3y 2.54
CAGR/Mean DD 3y 11.89
Sharpe Ratio 12m 1.07
Alpha 40.94
Beta 0.494
Volatility 36.37%
Current Volume 130.9k
Average Volume 20d 118.1k
Stop Loss 168.1 (-3.5%)
Signal -0.23

Piotroski VR‑10 (Strict, 0-10) 6.5

Net Income (84.6m TTM) > 0 and > 6% of Revenue (6% = 60.7m TTM)
FCFTA 0.08 (>2.0%) and ΔFCFTA -5.93pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 14.38% (prev 13.42%; Δ 0.96pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.13 (>3.0%) and CFO 125.0m > Net Income 84.6m (YES >=105%, WARN >=100%)
Net Debt (294.2m) to EBITDA (154.5m) ratio: 1.90 <= 3.0 (WARN <= 3.5)
Current Ratio 2.31 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (20.8m) change vs 12m ago -0.49% (target <= -2.0% for YES)
Gross Margin 23.05% (prev 22.33%; Δ 0.72pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 119.7% (prev 131.5%; Δ -11.80pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 16.42 (EBITDA TTM 154.5m / Interest Expense TTM 7.44m) >= 6 (WARN >= 3)

Altman Z'' 4.41

(A) 0.15 = (Total Current Assets 256.4m - Total Current Liabilities 110.9m) / Total Assets 988.3m
(B) 0.47 = Retained Earnings (Balance) 459.7m / Total Assets 988.3m
(C) 0.14 = EBIT TTM 122.1m / Avg Total Assets 845.5m
(D) 0.92 = Book Value of Equity 461.3m / Total Liabilities 503.7m
Total Rating: 4.41 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 77.36

1. Piotroski 6.50pt = 1.50
2. FCF Yield 2.11% = 1.05
3. FCF Margin 8.01% = 2.00
4. Debt/Equity 0.62 = 2.32
5. Debt/Ebitda 1.93 = 0.14
6. ROIC - WACC 16.69% = 12.50
7. RoE 18.35% = 1.53
8. Rev. Trend 47.12% = 2.36
9. Rev. CAGR 7.37% = 0.92
10. EPS Trend 43.60% = 1.09
11. EPS CAGR 19.50% = 1.95

What is the price of HWKN shares?

As of September 16, 2025, the stock is trading at USD 174.21 with a total of 130,941 shares traded.
Over the past week, the price has changed by -0.77%, over one month by +1.58%, over three months by +27.51% and over the past year by +48.80%.

Is Hawkins a good stock to buy?

Partly, yes. Based on ValueRay´s Fundamental Analyses, Hawkins (NASDAQ:HWKN) is currently (September 2025) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 77.36 and therefor a somewhat positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of HWKN is around 246.96 USD . This means that HWKN is currently undervalued and has a potential upside of +41.76% (Margin of Safety).

Is HWKN a buy, sell or hold?

Hawkins has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy HWKN.
  • Strong Buy: 0
  • Buy: 2
  • Hold: 0
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the HWKN price?

Issuer Target Up/Down from current
Wallstreet Target Price 153.8 -11.7%
Analysts Target Price 153.8 -11.7%
ValueRay Target Price 273.7 57.1%

Last update: 2025-09-11 04:40

HWKN Fundamental Data Overview

Market Cap USD = 3.56b (3.56b USD * 1.0 USD.USD)
CCE Cash And Equivalents = 14.5m USD (Cash And Short Term Investments, last quarter)
P/E Trailing = 42.0172
P/E Forward = 38.4615
P/S = 3.5198
P/B = 7.4069
P/EG = 2.8067
Beta = 0.857
Revenue TTM = 1.01b USD
EBIT TTM = 122.1m USD
EBITDA TTM = 154.5m USD
Long Term Debt = 288.3m USD (from longTermDebt, last quarter)
Short Term Debt = 9.81m USD (from shortTermDebt, last quarter)
Debt = 298.1m USD (Calculated: Short Term 9.81m + Long Term 288.3m)
Net Debt = 294.2m USD (from netDebt column, last quarter)
Enterprise Value = 3.85b USD (3.56b + Debt 298.1m - CCE 14.5m)
Interest Coverage Ratio = 16.42 (Ebit TTM 122.1m / Interest Expense TTM 7.44m)
FCF Yield = 2.11% (FCF TTM 81.0m / Enterprise Value 3.85b)
FCF Margin = 8.01% (FCF TTM 81.0m / Revenue TTM 1.01b)
Net Margin = 8.37% (Net Income TTM 84.6m / Revenue TTM 1.01b)
Gross Margin = 23.05% ((Revenue TTM 1.01b - Cost of Revenue TTM 778.6m) / Revenue TTM)
Tobins Q-Ratio = 8.34 (Enterprise Value 3.85b / Book Value Of Equity 461.3m)
Interest Expense / Debt = 1.10% (Interest Expense 3.27m / Debt 298.1m)
Taxrate = -26.26% (set to none) (-30.0m / 114.4m)
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 2.31 (Total Current Assets 256.4m / Total Current Liabilities 110.9m)
Debt / Equity = 0.62 (Debt 298.1m / last Quarter total Stockholder Equity 484.6m)
Debt / EBITDA = 1.93 (Net Debt 294.2m / EBITDA 154.5m)
Debt / FCF = 3.68 (Debt 298.1m / FCF TTM 81.0m)
Total Stockholder Equity = 461.3m (last 4 quarters mean)
RoA = 8.56% (Net Income 84.6m, Total Assets 988.3m )
RoE = 18.35% (Net Income TTM 84.6m / Total Stockholder Equity 461.3m)
RoCE = 16.29% (Ebit 122.1m / (Equity 461.3m + L.T.Debt 288.3m))
RoIC = 16.69% (Ebit 122.1m / (Assets 988.3m - Current Assets 256.4m))
WACC = unknown (E(3.56b)/V(3.86b) * Re(7.84%)) + (D(298.1m)/V(3.86b) * Rd(1.10%) * (1-Tc(none)))
Shares Correlation 3-Years: -63.64 | Cagr: -0.06%
Discount Rate = 7.84% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
[DCF Debug] Terminal Value 74.56% ; FCFE base≈88.3m ; Y1≈70.6m ; Y5≈47.9m
Fair Price DCF = 42.62 (DCF Value 889.7m / Shares Outstanding 20.9m; 5y FCF grow -23.99% → 3.0% )
Revenue Correlation: 47.12 | Revenue CAGR: 7.37%
Rev Growth-of-Growth: 10.26
EPS Correlation: 43.60 | EPS CAGR: 19.50%
EPS Growth-of-Growth: -14.78

Additional Sources for HWKN Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle